Hypothermic responses to 8-OH-DPAT in the Ts65Dn mouse model of Down syndrome

NeuroReport

Volumn 17, Issue 8, 2006, Pages 837-841

  Stasko, Melissa R ^a   Scott Mckean, Jonah J ^a   Costa, Alberto C S ^a,b  

^a UNIVERSITY OF DENVER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

5 HT1A receptor; 5 HT7 receptor; 8 OH DPAT; Down syndrome; G protein coupled neurotransmitter receptor; G protein activated potassium channel 2; Hypothermia

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; G PROTEIN ACTIVATED POTASSIUM CHANNEL 2; POTASSIUM CHANNEL; SEROTONIN 1A RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DOWN SYNDROME; GENE; GENE LOCATION; GIRK2 GENE; HYPOTHERMIA; MALE; MOUSE; MOUSE STRAIN; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TELEMETRY; TRISOMY 21;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DOWN SYNDROME; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; HYPOTHERMIA; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, NEUROLOGIC MUTANTS; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SYNAPTIC TRANSMISSION;

EID: 33744488780     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnr.0000220129.78726.bb     Document Type: Article

References (25)

1. Patterson D, Costa ACS. Down syndrome and genetics: a case of linked histories. Nat Rev Genet 2005; 6:137-147.
2. Boullin DJ, O'Brien RA. Abnormalities of 5-hydroxytryptamine uptake and binding by blood platelets from children with Down's syndrome. J Physiol 1971; 212:287-297.
3. Scott BS, Becker LE, Petit TL. Neurobiology of Down's syndrome. Prog Neurobiol 1983; 12:199-237.
4. Mann DM, Yates PO, Marcyniuk B, Ravindra CR. Pathological deficits in Down's syndrome of middle age. J Ment Defic Res 1985; 29:125-135.
5. Bar-Peled O, Gross-Isseroff R, Ben-Hur H, Hoskins I, Groner Y, Biegon A. Fetal human brain exhibits a prenatal peak in the density of serotonin 5-HT1A receptors. Neurosci Lett 1991; 127:173-176.
6. Gulesserian T, Engidawork E, Cairns N, Lubec G. Increased protein levels of serotonin transporter in frontal cortex of patients with Down syndrome. Neurosci Lett 2000; 296:53-57.
7. Seidl R, Kaehler ST, Prast H, Singewald N, Cairns N, Gratzer M, et al. Serotonin (5-HT) in brains of adult patients with Down syndrome. J Neural Transm 1999; 57(Suppl):221-232.
8. Cooper SA, Collacott RA. Clinical features and diagnostic criteria of depression in Down's syndrome. Br J Psychiatry 1994; 165:399-403.
9. Myers BA, Pueschel SM. Major depression in a small group of adults with Down syndrome. Res Dev Disabil 1995; 16:285-299.
10. Gedye A. Serotonergic treatment for aggression in a Down's syndrome adult showing signs of Alzheimer's disease. J Ment Defic Res 1991; 35:247-258.
11. Geldmacher DS, Lerner AJ, Voci JM, Noelker EA, Somple LC, Whitehouse PJ. Treatment of functional decline in adults with Down syndrome using selective serotonin-reuptake inhibitor drugs. J Geriatr Psychiatry Neurol 1997; 10:99-104.
12. Gardiner K, Fortna A, Bechtel L, Davisson MT. Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions. Gene 2003; 318:137-147.
13. Davisson MT, Costa ACS. Mouse models of Down syndrome. Adv Neurochem 1999; 9:297-327.
14. O'Doherty A, Ruf S, Mulligan C, Hildreth V, Errington ML, Cooke S, et al. An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science 2005; 309:2033-2037.
15. Clark S, Schwalbe J, Stasko MR, Yarowsky PJ, Costa ACS. Fluoxetine rescues deficient neurogenesis in hippocampus of the mouse model for Down syndrome Ts65Dn. Exp Neurol (in press).
16. Costa ACS, Stasko MR, Stoffel M, Scott-McKean JJ. G protein-gated Potassium (GIRK) channels containing the GIRK2 subunit are control hubs for pharmacologically-induced hypothermic responses. J Neurosci 2005; 25:7801-7804.
17. El Yacoubi M, Bouali S, Popa D, Naudon L, Leroux-Nicollet I, Hamon M, et al. Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression. Proc Natl Acad Sci USA 2003; 100:6227-6232.
18. Overstreet DH, Friedman E, Mathe AA, Yadid G. The Flinders sensitive line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev 2005; 29:739-759.
19. Davisson MT, Schmidt C, Akeson EC. Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome. Prog Clin Biol Res 1990; 360:263-280.
20. Balcells-Olivero M, Cousins MS, Seiden LS. Holtzman and Harlan Sprague-Dawley rats: differences in DRL 72-sec performance and 8-hydroxy-di-propylamino tetralin-induced hypothermia. J Pharmacol Exp Ther 1998; 286:742-752.
21. Meller E, Chalfin M, Bohmaker K. Serotonin 5-HT1A receptor-mediated hypothermia in mice: absence of spare receptors and rapid induction of tolerance. Pharmacol Biochem Behav 1992; 43:405-411.
22. Heisler LK, Chu HM, Brennan TJ, Danao JA, Bajwa P, Parsons LH, et al. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci USA 1998; 95:15049-15054.
23. Hedlund PB, Danielson PE, Thomas EA, Slanina K, Carson MJ, Sutcliffe JG. No hypothermic response to serotonin in 5-HT7 receptor knockout mice. Proc Natl Acad Sci USA 2003; 100:1375-1380.
24. Stockmeier CA, Shapiro LA, Dilley GE, Kolli TN, Friedman L, Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J Neurosci 1998; 18:7394-7401.
25. Harashima C, Jacobowitz DM, Witta J, Borke RC, Best TK, Siarey RJ, et al. Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of Down syndrome. J Comp Neurol 2006; 494:815-833.